Catalyst Wire Dossier Catalyst Wire Dossier

CLEVIPREX

clevidipine · Fresenius Kabi Austria GmbH
Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for CLEVIPREX, covering 2008-08-01 to 2021-11-08. Get the full timeline:

Most recent: Clinical Trial Update: Clevidipine (Cleviprex®) Compared With Urapidil (Ebrantil®) [Phase 4]

See pricing